Toshihiko Torigoe

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Sapporo Medical University, Sumitomo Dainippon Pharma Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihiko Torigoe. Retrieved from https://idiyas.com/inventor/toshihiko-torigoe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 9(Granted Patents)

Location History:

Hokkaido, JP (2013)
Sapporo, JP (2002 - 2022)

Company Filing History:

7 out of 36

Sapporo Medical University

patents

3 out of 110

Sumitomo Dainippon Pharma Co., Ltd.

patents

2 out of 140

Dainippon Sumitomo Pharma Co., Ltd.

Medical Biological Laboratories Co., Ltd.

patents

6. 1 out of 66

Sumitomo Pharma Co., Ltd.

patents

7. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637500 - TUMOR ANTIGEN PEPTIDE (2026-05-26),

2. 11382952 - Molecular marker for cancer stem cell (2022-07-12),

3. 11028136 - Tumor antigen peptide (2021-06-08),

4. 10765729 - Tumor antigen peptide (2020-09-08),

5. 10080776 - Molecular marker for cancer stem cell (2018-09-25),

6. 9399760 - Molecular marker for cancer stem cell (2016-07-26),

7. 8541544 - Molecular marker for cancer stem cell (2013-09-24),

8. 7601801 - HLA-A24 binding cancer antigen peptide derived from livin (2009-10-13),

9. 7030222 - Human gastric cancer antigen gene and gastric cancer antigen protein (2006-04-18),

10. 6444800 - Human gastric cancer antigen gene and gastric cancer antigen protein (2002-09-03),

Title: Innovations of Toshihiko Torigoe in Cancer Research

Introduction

Toshihiko Torigoe is a prominent inventor based in Sapporo, Japan, known for his significant contributions to cancer research. He holds a total of nine patents, showcasing his dedication to advancing medical science and improving cancer treatment methodologies.

Latest Patents

Among his latest patents, Torigoe has developed a molecular marker for cancer stem cells. This marker allows for the detection of cancer stem cells within a cell mass, distinguishing them from normal cells and other cancer cells. His work includes a method for determining the presence of these stem cells and a kit designed for their detection. Additionally, he has created a tumor antigen peptide that is specifically presented on cancer and cancer stem cells. This peptide is integral to pharmaceutical compositions aimed at preventing and treating cancer.

Career Highlights

Toshihiko Torigoe has worked with esteemed institutions such as Sapporo Medical University and Sumitomo Dainippon Pharma Co., Ltd. His research has significantly impacted the field of oncology, particularly in the identification and treatment of cancer stem cells.

Collaborations

Torigoe has collaborated with notable colleagues, including Yoshihiko Hirohashi and Noriyuki Sato. Their combined expertise has furthered advancements in cancer research and treatment strategies.

Conclusion

Toshihiko Torigoe's innovative work in cancer research exemplifies the critical role of inventors in the medical field. His patents and collaborations continue to pave the way for new treatments and improved patient outcomes.

Profile summary based on public USPTO records.